NCT06906523

Brief Summary

Introduction. From the age of 80 onwards, more than 50% of people suffer from sarcopenia. The loss of muscle strength leads to a loss of muscle power, impairing functionality and preventing the correct performance of activities of daily living. Objective. To analyse the efficacy of blood flow restriction in older adult patients by evaluating changes in the variables muscle power and strength, physical condition and functionality of the lower limbs. Material and method. Randomised single-blind clinical study. Thirty-six older adults will be recruited and randomised to the experimental and control groups. The intervention will have a duration of 4 weeks, with 2 weekly sessions. The intervention will consist of an intervention by performing 3 quadriceps strength exercises, with a 40% restriction. The primary variable of the study will be muscle power (Sit To Stand 5 times) and the secondary variables will be muscle strength (dynamometry), physical condition (Timed Up and Go) and functionality and autonomy (Barthel index)

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

March 12, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2025

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2025

Completed
Last Updated

April 4, 2025

Status Verified

February 1, 2025

Enrollment Period

1 month

First QC Date

March 11, 2025

Last Update Submit

April 1, 2025

Conditions

Keywords

Blood flow restrictionOlder adultsMuscle powerMuscle strengthFunctionalityPhysical fitness

Outcome Measures

Primary Outcomes (1)

  • Change from baseline muscle power after treatment and at four weeks

    Muscle power will be assessed with the Sit To Stand 5 times. This tool consists of getting up and sitting down from a chair five times. This instrument has shown high reliability (CCI= 0.95). The unit of measurement is time in seconds, where the shorter the time the greater the muscle power

    Screening visit, within the first seven days after treatment and four weeks follow-up visit

Secondary Outcomes (3)

  • Change from baseline muscle strength after treatment and at four weeks

    Screening visit, within the first seven days after treatment and four weeks follow-up visit

  • Change from baseline physical condition after treatment and at four weeks

    Screening visit, within the first seven days after treatment and four weeks follow-up visit

  • Change from baseline functionality after treatment and at four weeks

    Screening visit, within the first seven days after treatment and four weeks follow-up visit

Study Arms (2)

Blood flow restriction

EXPERIMENTAL

An exercise protocol will be applied to work on lower limb strength in extension, with the application of BFR, with two 30-minute sessions per week for four weeks. The exercise protocol, based on previous studies in older adults, will consist of three exercises: climbing on a step, knee extension from a seated position and sitting down and getting up from a chair.

Other: Blood flow restriction training

No intervention

NO INTERVENTION

Patients included in the control group will not receive any intervention, maintaining their activities of daily living in the same way as before the study.

Interventions

The intensity of the work will be set at around 40% of the maximum intensity that can be executed in a single repetition (1RM). To reach the established intensity, weights, weighted ankle supports and rubber bands of different resistances will be used. Three sets of 8-10 repetitions will be performed with breaks of 1-2 seconds between repetitions and 2-3 minutes between sets. The intensity of the work will be established by applying the rate of perceived exertion. A blood flow restriction device will be used (Akrafit, Valencia, Spain model).

Blood flow restriction

Eligibility Criteria

Age65 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Older adults aged 65 to 80 years
  • Independent for standing and walking with the help of assistive devices such as cane and walker
  • Both genders
  • Normotensive or hypertensive with controlled BP (systolic blood pressure \<140 mmHg)
  • Sign the informed consent form.

You may not qualify if:

  • People dependent for the performance of activities of daily living.
  • People with cognitive impairments that limit the performance of the intervention or assessments.
  • Persons undergoing total hip or knee arthroplasty
  • Persons receiving physiotherapy treatment at the time of the study
  • History of deep vein thrombosis (DVT) or pulmonary embolism
  • History of myocardial infarction or stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Católica San Antonio de Murcia

Murcia, Spain

Location

MeSH Terms

Interventions

Blood Flow Restriction Therapy

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 11, 2025

First Posted

April 2, 2025

Study Start

March 12, 2025

Primary Completion

April 13, 2025

Study Completion

April 15, 2025

Last Updated

April 4, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations